SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Randomized placebo‐controlled study of oral calcium carbonate administration in plateletpheresis: I. Associations with donor symptoms
0 references·8 citing·28 second hop
Randomized placebo‐controlled study of oral calcium carbonate administration in plateletpheresis: I. Associations with donor symptoms (2003)Randomized placebo‐controlled study of or…Delayed adverse events in male plateletpheresis donors: Initial insights on donor safety (2019)Delayed adverse events in mal…A liquid calcium+vitamin D3 supplement is effective prophylaxis against hypocalcemic toxicity during apheresis platelet donation (2017)A liquid calcium+vitamin D3 s…Citrate anticoagulation: Are blood donors donating bone? (2015)Citrate anticoagulation: Are …Evaluation of donor factors contributing to plateletpheresis yields among apheresis platelet donors (2013)Evaluation of donor factors c…Do we really know the real risks of apheresis donation? (2007)Do we really know the real ri…Prospective, paired crossover comparison of multiple, single‐needle plateletpheresis procedures with the Amicus and Trima Accel cell separators (2006)Prospective, paired crossover…Hematomas in multicomponent apheresis: searching for related factors (2006)Hematomas in multicomponent a…What’s happening: An overview of potential adverse reactions associated with apheresis technology (2005)What’s happening: An overview…Standards for blood banks and transfusion services. (1977)First year donation patterns predict long‐term commitment for first‐time donors (2005)Blood donor satisfaction and intention of future donation (2008)Young apheresis platelet donors show significant and sustained growth over the last decade in the US, 2010–2019: A favorable sign of the resiliency of the platelet supply (2023)Plateletpheresis efficiency: a comparison of the Spectra LRS and AMICUS separators (1999)National audit of citrate toxicity in plateletpheresis donors (2002)A randomized crossover trial comparing three plateletpheresis machines (2005)Paired crossover study of two plateletpheresis systems concerning platelet product quality and donor comfort (2009)Donor safety in triple plateletpheresis: results from the German and Austrian Plateletpheresis Study Group multicenter trial (2012)Comparison of plateletpheresis on the Fenwal Amicus, Fresenius COM.TEC, and Trima Accel Cell separators (2014)Frequency of immediate adverse effects associated with apheresis donation (1998)Adverse Events in Platelet Apheresis Donors: A Multivariate Analysis in a Hospital‐Based Program (1999)Vasovagal reactions in apheresis donors (2002)A case‐controlled multicenter study of vasovagal reactions in blood donors: influence of sex, age, donation status, weight, blood pressure, and pulse (1999)Adverse effects in blood donors after whole‐blood donation: a study of 1000 blood donors interviewed 3 weeks after whole‐blood donation (2003)The effect of whole‐blood donor adverse events on blood donor return rates (2006)Prevalence and predictors of adverse reactions in plateletpheresis donors with the perspective of donor safety in a tertiary care hospital of Northern India (2020)Vasovagal reaction rates and body weight: findings in high‐ and low‐risk populations (2003)Complications of donor apheresis (2005)The N ational H eart, L ung, and B lood I nstitute R ecipient E pidemiology and D onor E valuation S tudy ( REDS ‐ III ): a research program striving to improve blood donor and transfusion recipient outcomes (2013)The new S candinavian D onations and T ransfusions database ( SCANDAT2 ): a blood safety resource with added versatility (2015)Immunoglobulin G levels during collection of large volume plasma for fractionation (2017)Impact of frequent apheresis blood donation on bone density: A prospective, longitudinal, randomized, controlled trial (2018)A donor safety evidence literature review of the short‐ and long‐term effects of plasmapheresis (2023)Randomized placebo‐controlled study of oral calcium carbonate supplementation in plateletpheresis: II. Metabolic effects (2003)Risk factors associated with the occurrence of adverse events in plateletpheresis donation (2014)Adverse reactions in blood and apheresis donors: experience from two Italian transfusion centres. (2009)Moderate and severe adverse events associated with apheresis donations: incidences and risk factors (2009)
this work references cited by second hop

References

No references inside the corpus for this window.

Cited by

  • 2006Prospective, paired crossover comparison of multiple, single‐needle plateletpheresis procedures with the Amicus and Trima Accel cell separators33 cited
  • 2015Citrate anticoagulation: Are blood donors donating bone?21 cited
  • 2007Do we really know the real risks of apheresis donation?12 cited
  • 2017A liquid calcium+vitamin D3 supplement is effective prophylaxis against hypocalcemic toxicity during apheresis platelet donation11 cited
  • 2013Evaluation of donor factors contributing to plateletpheresis yields among apheresis platelet donors9 cited
  • 2006Hematomas in multicomponent apheresis: searching for related factors9 cited
  • 2005What’s happening: An overview of potential adverse reactions associated with apheresis technology8 cited
  • 2019Delayed adverse events in male plateletpheresis donors: Initial insights on donor safety7 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work